Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects Daisy JindalMonika TandonK.K. Pillai Clinical Trials 30 August 2005 Pages: 621 - 625
CYP2C9*3 allelic variant is associated with metabolism of irbesartan in Chinese population Xiumei HongShanchun ZhangXiping Xu Pharmacogenetics 11 August 2005 Pages: 627 - 634
Simultaneous genotyping of CYP2C9*2, *3, and 5′ flanking region (C-1189T) polymorphisms in a Spanish population through a new minisequencing multiplex single-base extension analysis Sergi MasAnna CrescentiAmalia Lafuente Pharmacogenetics 05 August 2005 Pages: 635 - 641
Prescription audit adjunct to rational pharmacotherapy education improves prescribing skills of medical students Ahmet AkiciM. Zafer GörenŞule Oktay Pharmacoepidemiology and Prescription 27 September 2005 Pages: 643 - 650
General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies Allan BuusmanJakob KragstrupMorten Andersen Pharmacoepidemiology and Prescription 27 September 2005 Pages: 651 - 656
Understanding adherence to official guidelines on statin prescribing in primary health care—a multi-level methodological approach H. OhlssonU. LindbladJ. Merlo Pharmacoepidemiology and Prescription 25 August 2005 Pages: 657 - 665
Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease Sylvie PerreaultLucie BlaisJohanne Collin Pharmacoepidemiology and Prescription 08 September 2005 Pages: 667 - 674
Drug-drug interactions among recently hospitalised patients – frequent but mostly clinically insignificant Bente GlintborgStig Ejdrup AndersenKim Dalhoff Pharmacoepidemiology and Prescription 27 July 2005 Pages: 675 - 681
Abstracts of the 7th Annual Congress on Clinical Pharmacology Abstracts 11 October 2005 Pages: 683 - 726
